Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaik Fakiruddin, Kamal, Ghazalli, Nadiah, Lim, Moon Nian, Zakaria, Zubaidah, Abdullah, Syahril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121609/
https://www.ncbi.nlm.nih.gov/pubmed/30060445
http://dx.doi.org/10.3390/ijms19082188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121609/
https://www.ncbi.nlm.nih.gov/pubmed/30060445
http://dx.doi.org/10.3390/ijms19082188

Ejemplares similares